{
  "timestamp": "2026-01-07T17:15:01.340754",
  "total_queries": 86,
  "queries_analyzed": 86,
  "queries_with_errors": 0,
  "ground_truth": [
    {
      "query_id": "DG_001",
      "question": "How does capecitabine interact with DPYD c.2846A>T in cancer?",
      "search_query": "\"capecitabine\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Capecitabine",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Fluorouracil",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Male",
        "Female",
        "DPYD",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "Middle Aged",
        "Aged",
        "Neoplasms",
        "capecitabine",
        "Adult",
        "Retrospective Studies",
        "5-fluorouracil",
        "Pharmacogenetics",
        "Prospective Studies",
        "fluoropyrimidines"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_002",
      "question": "How does capecitabine interact with DPYD c.2846A>T in cancer?",
      "search_query": "\"capecitabine\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Capecitabine",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Fluorouracil",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Male",
        "Female",
        "DPYD",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "Middle Aged",
        "Aged",
        "Neoplasms",
        "capecitabine",
        "Adult",
        "Retrospective Studies",
        "5-fluorouracil",
        "Pharmacogenetics",
        "Prospective Studies",
        "fluoropyrimidines"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_003",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_004",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_005",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_006",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_007",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_008",
      "question": "How does capecitabine interact with DPYD c.1903A>G in cancer?",
      "search_query": "\"capecitabine\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Capecitabine",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Fluorouracil",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Male",
        "Female",
        "DPYD",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "Middle Aged",
        "Aged",
        "Neoplasms",
        "capecitabine",
        "Adult",
        "Retrospective Studies",
        "5-fluorouracil",
        "Pharmacogenetics",
        "Prospective Studies",
        "fluoropyrimidines"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_009",
      "question": "How does 5-fluorouracil interact with DPYD in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_010",
      "question": "How does mercaptopurine interact with TPMT *3A in cancer?",
      "search_query": "\"mercaptopurine\" AND TPMT AND cancer",
      "paper_count": 99,
      "top_keywords": [
        "Humans",
        "Mercaptopurine",
        "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
        "Methyltransferases",
        "Child",
        "Male",
        "Female",
        "Pyrophosphatases",
        "Antimetabolites, Antineoplastic",
        "Child, Preschool",
        "Adolescent",
        "Genotype",
        "Polymorphism, Single Nucleotide",
        "NUDT15",
        "Pharmacogenetics",
        "TPMT",
        "Methotrexate",
        "Infant",
        "6-mercaptopurine",
        "Nudix Hydrolases"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_011",
      "question": "How does 5-fluorouracil interact with DPYD A348T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_012",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18139713G>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_013",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18130698delA in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_014",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18149023G>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_015",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18130729C>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_016",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18133864G>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_017",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18143662delA in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_018",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18143717C>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_019",
      "question": "How does 5-fluorouracil interact with DPYD chr6:g.18130763G>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_020",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97679174G>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_021",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97828158C>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_022",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97573967C>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_023",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97721603A>G in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_024",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97079145G>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_025",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97306282G>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_026",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97593336A>G in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_027",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97306235delA in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_028",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97573918C>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_029",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97079073C>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_030",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97883365C>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_031",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97679126T>G in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_032",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97082458T>C in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_033",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97721543A>G in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_034",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97699457G>A in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_035",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97515906T>G in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_036",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97234900A>G in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_037",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97721569A>C in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_038",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97549703G>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_039",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97595138G>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "DG_040",
      "question": "How does 5-fluorouracil interact with DPYD chr1:g.97306195C>T in cancer?",
      "search_query": "\"5-fluorouracil\" AND DPYD AND cancer",
      "paper_count": 98,
      "top_keywords": [
        "Humans",
        "Fluorouracil",
        "Dihydrouracil Dehydrogenase (NADP)",
        "Antimetabolites, Antineoplastic",
        "Genotype",
        "Capecitabine",
        "Male",
        "DPYD",
        "Female",
        "5-fluorouracil",
        "Middle Aged",
        "Aged",
        "Adult",
        "Neoplasms",
        "Dihydropyrimidine Dehydrogenase Deficiency",
        "pharmacogenetics",
        "Pharmacogenetics",
        "Colorectal Neoplasms",
        "Uracil",
        "capecitabine"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_001",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.C61G?",
      "search_query": "\"Olaparib\" AND BRCA1 AND ovarian cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "Ovarian Neoplasms",
        "Phthalazines",
        "Piperazines",
        "BRCA1 Protein",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "BRCA2 Protein",
        "Middle Aged",
        "Cell Line, Tumor",
        "Aged",
        "Adult",
        "ovarian cancer",
        "Mutation",
        "Drug Resistance, Neoplasm",
        "Olaparib",
        "Ovarian cancer",
        "PARP inhibitor",
        "Antineoplastic Agents",
        "Antineoplastic Combined Chemotherapy Protocols"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_002",
      "question": "What mechanisms does Olaparib target in breast cancer with p.C61G?",
      "search_query": "\"Olaparib\" AND BRCA1 AND breast cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "Phthalazines",
        "Piperazines",
        "BRCA1 Protein",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Breast Neoplasms",
        "BRCA2 Protein",
        "Cell Line, Tumor",
        "Middle Aged",
        "Olaparib",
        "Mutation",
        "Triple Negative Breast Neoplasms",
        "Aged",
        "Adult",
        "Antineoplastic Agents",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Animals",
        "PARP inhibitor",
        "Drug Resistance, Neoplasm"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_003",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.K3326*?",
      "search_query": "\"Olaparib\" AND BRCA2 AND prostate cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Male",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Prostatic Neoplasms, Castration-Resistant",
        "Phthalazines",
        "Piperazines",
        "BRCA2 Protein",
        "Prostatic Neoplasms",
        "Mutation",
        "BRCA1 Protein",
        "Antineoplastic Agents",
        "Neoplasm Metastasis",
        "Prostate cancer",
        "prostate cancer",
        "Olaparib",
        "Aged",
        "BRCA2",
        "DNA Repair",
        "PARP inhibitor",
        "Middle Aged"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_004",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.K3326*?",
      "search_query": "\"Olaparib\" AND BRCA2 AND ovarian cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "Ovarian Neoplasms",
        "BRCA2 Protein",
        "BRCA1 Protein",
        "Phthalazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Piperazines",
        "Aged",
        "Middle Aged",
        "Adult",
        "Mutation",
        "PARP inhibitors",
        "Antineoplastic Agents",
        "Olaparib",
        "Breast Neoplasms",
        "ovarian cancer",
        "Carcinoma, Ovarian Epithelial",
        "Ovarian cancer",
        "Cell Line, Tumor"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_005",
      "question": "What mechanisms does Olaparib target in breast cancer with p.R346fs?",
      "paper_count": 0,
      "top_keywords": [
        "target",
        "mechanism",
        "mechanisms",
        "olaparib",
        "breast",
        "cancer"
      ],
      "keyword_counts": {
        "target": 2,
        "mechanism": 1,
        "mechanisms": 1,
        "olaparib": 1,
        "breast": 1,
        "cancer": 1
      },
      "method": "portal"
    },
    {
      "query_id": "SL_006",
      "question": "What mechanisms does Ceralasertib target in prostate cancer with p.R175H?",
      "paper_count": 0,
      "top_keywords": [
        "target",
        "mechanism",
        "mechanisms",
        "ceralasertib",
        "prostate",
        "cancer"
      ],
      "keyword_counts": {
        "target": 2,
        "mechanism": 1,
        "mechanisms": 1,
        "ceralasertib": 1,
        "prostate": 1,
        "cancer": 1
      },
      "method": "portal"
    },
    {
      "query_id": "SL_007",
      "question": "What mechanisms does Adavosertib target in ovarian cancer with p.R175H?",
      "search_query": "\"Adavosertib\" AND TP53 AND ovarian cancer",
      "paper_count": 9,
      "top_keywords": [
        "Humans",
        "Female",
        "Pyrazoles",
        "Pyrimidinones",
        "Ovarian Neoplasms",
        "Tumor Suppressor Protein p53",
        "Protein-Tyrosine Kinases",
        "Cell Cycle Proteins",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Middle Aged",
        "Antineoplastic Agents",
        "Carboplatin",
        "Aged",
        "Protein Kinase Inhibitors",
        "Animals",
        "Targeted therapy",
        "Protein Serine-Threonine Kinases",
        "Drug Resistance, Neoplasm",
        "Immunotherapy",
        "Disease-Free Survival"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_008",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "search_query": "\"Olaparib\" AND ATM AND breast cancer",
      "paper_count": 54,
      "top_keywords": [
        "Humans",
        "Phthalazines",
        "Piperazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Female",
        "Cell Line, Tumor",
        "Ataxia Telangiectasia Mutated Proteins",
        "Animals",
        "Antineoplastic Agents",
        "DNA Damage",
        "BRCA1 Protein",
        "Breast Neoplasms",
        "Mice",
        "PARP inhibitor",
        "DNA Repair",
        "Neoplasms",
        "ATM",
        "BRCA2 Protein",
        "Triple Negative Breast Neoplasms",
        "Mutation"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_009",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "search_query": "\"Olaparib\" AND PALB2 AND prostate cancer",
      "paper_count": 19,
      "top_keywords": [
        "Humans",
        "Male",
        "Phthalazines",
        "Piperazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Prostatic Neoplasms",
        "Mutation",
        "Antineoplastic Agents",
        "Prostate cancer",
        "Prostatic Neoplasms, Castration-Resistant",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Female",
        "Olaparib",
        "PARP inhibitors",
        "Aged",
        "Middle Aged",
        "Aged, 80 and over",
        "Indoles",
        "Germ-Line Mutation",
        "prostate cancer"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_010",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "search_query": "\"Olaparib\" AND RAD51C AND ovarian cancer",
      "paper_count": 11,
      "top_keywords": [
        "Humans",
        "Female",
        "Ovarian Neoplasms",
        "Middle Aged",
        "DNA-Binding Proteins",
        "Aged",
        "Adult",
        "Phthalazines",
        "Piperazines",
        "RAD51C",
        "Mutation",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Genetic Predisposition to Disease",
        "BRCA1 Protein",
        "Bevacizumab",
        "Genomic Instability",
        "Ovarian cancer",
        "Breast Neoplasms",
        "Mutation, Missense",
        "Colorectal Neoplasms"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_011",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "search_query": "\"Olaparib\" AND RAD51D AND breast cancer",
      "paper_count": 5,
      "top_keywords": [
        "Humans",
        "Phthalazines",
        "Piperazines",
        "DNA-Binding Proteins",
        "Adult",
        "Female",
        "Genomic Instability",
        "Mutation",
        "Ovarian Neoplasms",
        "Male",
        "Recombinational DNA Repair",
        "Aged",
        "Middle Aged",
        "BRCA1 Protein",
        "BRCA2 Protein",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Clinical Trials as Topic",
        "Genomic instability",
        "Olaparib",
        "Ovarian cancer"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_012",
      "question": "What mechanisms does Ceralasertib target in prostate cancer with p.??",
      "paper_count": 0,
      "top_keywords": [
        "target",
        "mechanism",
        "mechanisms",
        "ceralasertib",
        "prostate",
        "cancer"
      ],
      "keyword_counts": {
        "target": 2,
        "mechanism": 1,
        "mechanisms": 1,
        "ceralasertib": 1,
        "prostate": 1,
        "cancer": 1
      },
      "method": "portal"
    },
    {
      "query_id": "SL_013",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "search_query": "\"Olaparib\" AND CDK12 AND ovarian cancer",
      "paper_count": 8,
      "top_keywords": [
        "Phthalazines",
        "Female",
        "Humans",
        "Piperazines",
        "Ovarian Neoplasms",
        "Animals",
        "Mice",
        "Cyclin-Dependent Kinases",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Cell Line, Tumor",
        "Olaparib",
        "ovarian cancer",
        "Antineoplastic Agents",
        "Cystadenocarcinoma, Serous",
        "Mutation",
        "Enzyme Inhibitors",
        "Mice, Nude",
        "Xenograft Model Antitumor Assays",
        "Olaparib resistance",
        "Ovarian cancer"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_014",
      "question": "What mechanisms does Olaparib target in breast cancer with p.C61G?",
      "search_query": "\"Olaparib\" AND BRCA1 AND breast cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "Phthalazines",
        "Piperazines",
        "BRCA1 Protein",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Breast Neoplasms",
        "BRCA2 Protein",
        "Cell Line, Tumor",
        "Middle Aged",
        "Olaparib",
        "Mutation",
        "Triple Negative Breast Neoplasms",
        "Aged",
        "Adult",
        "Antineoplastic Agents",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Animals",
        "PARP inhibitor",
        "Drug Resistance, Neoplasm"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_015",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.C61G?",
      "search_query": "\"Olaparib\" AND BRCA1 AND prostate cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Male",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Prostatic Neoplasms, Castration-Resistant",
        "Phthalazines",
        "Piperazines",
        "BRCA1 Protein",
        "BRCA2 Protein",
        "Prostatic Neoplasms",
        "Antineoplastic Agents",
        "Mutation",
        "Prostate cancer",
        "Olaparib",
        "PARP inhibitor",
        "PARP inhibitors",
        "prostate cancer",
        "Neoplasm Metastasis",
        "Antineoplastic Combined Chemotherapy Protocols",
        "olaparib",
        "Aged"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_016",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.K3326*?",
      "search_query": "\"Olaparib\" AND BRCA2 AND ovarian cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "Ovarian Neoplasms",
        "BRCA2 Protein",
        "BRCA1 Protein",
        "Phthalazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Piperazines",
        "Aged",
        "Middle Aged",
        "Adult",
        "Mutation",
        "PARP inhibitors",
        "Antineoplastic Agents",
        "Olaparib",
        "Breast Neoplasms",
        "ovarian cancer",
        "Carcinoma, Ovarian Epithelial",
        "Ovarian cancer",
        "Cell Line, Tumor"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_017",
      "question": "What mechanisms does Olaparib target in breast cancer with p.K3326*?",
      "search_query": "\"Olaparib\" AND BRCA2 AND breast cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "BRCA2 Protein",
        "BRCA1 Protein",
        "Phthalazines",
        "Piperazines",
        "Breast Neoplasms",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Middle Aged",
        "Aged",
        "Adult",
        "Olaparib",
        "Mutation",
        "Triple Negative Breast Neoplasms",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Germ-Line Mutation",
        "Antineoplastic Agents",
        "Ovarian Neoplasms",
        "olaparib",
        "BRCA"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_018",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.R346fs?",
      "paper_count": 0,
      "top_keywords": [
        "target",
        "mechanism",
        "mechanisms",
        "olaparib",
        "prostate",
        "cancer"
      ],
      "keyword_counts": {
        "target": 2,
        "mechanism": 1,
        "mechanisms": 1,
        "olaparib": 1,
        "prostate": 1,
        "cancer": 1
      },
      "method": "portal"
    },
    {
      "query_id": "SL_019",
      "question": "What mechanisms does Ceralasertib target in ovarian cancer with p.R175H?",
      "paper_count": 0,
      "top_keywords": [
        "target",
        "mechanism",
        "mechanisms",
        "ceralasertib",
        "ovarian",
        "cancer"
      ],
      "keyword_counts": {
        "target": 2,
        "mechanism": 1,
        "mechanisms": 1,
        "ceralasertib": 1,
        "ovarian": 1,
        "cancer": 1
      },
      "method": "portal"
    },
    {
      "query_id": "SL_020",
      "question": "What mechanisms does Adavosertib target in breast cancer with p.R175H?",
      "search_query": "\"Adavosertib\" AND TP53 AND breast cancer",
      "paper_count": 2,
      "top_keywords": [
        "Humans",
        "Protein-Tyrosine Kinases",
        "Cell Cycle Proteins",
        "Protein Kinase Inhibitors",
        "Antineoplastic Agents",
        "Animals",
        "Pyrazoles",
        "Pyrimidinones",
        "Neoplasms",
        "Clinical Trials as Topic",
        "Molecular Targeted Therapy",
        "Clinical trials",
        "DNA damage response",
        "Drug resistance",
        "Targeted therapy",
        "WEE1 kinase",
        "Apoptosis",
        "Breast Neoplasms",
        "Cell Line",
        "Cell Line, Tumor"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_021",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "search_query": "\"Olaparib\" AND ATM AND prostate cancer",
      "paper_count": 65,
      "top_keywords": [
        "Humans",
        "Male",
        "Prostatic Neoplasms, Castration-Resistant",
        "Phthalazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Piperazines",
        "Mutation",
        "Antineoplastic Agents",
        "Ataxia Telangiectasia Mutated Proteins",
        "Prostatic Neoplasms",
        "Aged",
        "Middle Aged",
        "Neoplasm Metastasis",
        "BRCA1 Protein",
        "BRCA2 Protein",
        "PARP inhibitor",
        "Olaparib",
        "DNA Repair",
        "olaparib",
        "Aged, 80 and over"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_022",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "search_query": "\"Olaparib\" AND PALB2 AND ovarian cancer",
      "paper_count": 20,
      "top_keywords": [
        "Humans",
        "Female",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "BRCA2 Protein",
        "Phthalazines",
        "Ovarian Neoplasms",
        "Piperazines",
        "BRCA1 Protein",
        "Antineoplastic Agents",
        "PARP inhibitors",
        "Recombinational DNA Repair",
        "Mutation",
        "Clinical Trials as Topic",
        "Olaparib",
        "Animals",
        "Xenograft Model Antitumor Assays",
        "Breast Neoplasms",
        "Cell Line, Tumor",
        "Breast cancer",
        "Fanconi Anemia Complementation Group N Protein"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_023",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "search_query": "\"Olaparib\" AND RAD51C AND breast cancer",
      "paper_count": 9,
      "top_keywords": [
        "Humans",
        "Female",
        "Mutation",
        "Phthalazines",
        "Piperazines",
        "DNA-Binding Proteins",
        "Male",
        "Adult",
        "Middle Aged",
        "Ovarian Neoplasms",
        "Genetic Predisposition to Disease",
        "Aged",
        "BRCA1 Protein",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Breast Neoplasms",
        "Mutation, Missense",
        "Antineoplastic Combined Chemotherapy Protocols",
        "RAD51C",
        "Colorectal Neoplasms",
        "DNA Mutational Analysis"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_024",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "search_query": "\"Olaparib\" AND RAD51D AND prostate cancer",
      "paper_count": 1,
      "top_keywords": [
        "Adolescent",
        "Adult",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Humans",
        "Male",
        "Pain",
        "Phthalazines",
        "Physicians",
        "Piperazines",
        "Prostatic Neoplasms, Castration-Resistant",
        "Quality of Life",
        "Recombinational DNA Repair"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_025",
      "question": "What mechanisms does Ceralasertib target in ovarian cancer with p.??",
      "search_query": "\"Ceralasertib\" AND ARID1A AND ovarian cancer",
      "paper_count": 2,
      "top_keywords": [
        "Female",
        "Humans",
        "Ovarian Neoplasms",
        "Protein Kinase Inhibitors",
        "Adenocarcinoma, Clear Cell",
        "Ataxia Telangiectasia Mutated Proteins",
        "Carcinoma, Ovarian Epithelial",
        "Cell Cycle Proteins",
        "China",
        "Protein-Tyrosine Kinases",
        "TOR Serine-Threonine Kinases",
        "ATR",
        "Ovarian clear cell carcinoma",
        "WEE1",
        "DNA-Binding Proteins",
        "Endometrial Neoplasms",
        "Indoles",
        "Morpholines",
        "Multicenter Studies as Topic",
        "Neoplasm Recurrence, Local"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_026",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "search_query": "\"Olaparib\" AND CDK12 AND breast cancer",
      "paper_count": 7,
      "top_keywords": [
        "Humans",
        "Phthalazines",
        "Piperazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Female",
        "Triple Negative Breast Neoplasms",
        "Drug Resistance, Neoplasm",
        "Antineoplastic Agents",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Male",
        "Recombinational DNA Repair",
        "Animals",
        "Enzyme Inhibitors",
        "Mice",
        "Mice, Nude",
        "Xenograft Model Antitumor Assays",
        "Cisplatin",
        "Gemcitabine",
        "BRCA1 Protein",
        "Cell Line, Tumor"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_027",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.C61G?",
      "search_query": "\"Olaparib\" AND BRCA1 AND prostate cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Male",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Prostatic Neoplasms, Castration-Resistant",
        "Phthalazines",
        "Piperazines",
        "BRCA1 Protein",
        "BRCA2 Protein",
        "Prostatic Neoplasms",
        "Antineoplastic Agents",
        "Mutation",
        "Prostate cancer",
        "Olaparib",
        "PARP inhibitor",
        "PARP inhibitors",
        "prostate cancer",
        "Neoplasm Metastasis",
        "Antineoplastic Combined Chemotherapy Protocols",
        "olaparib",
        "Aged"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_028",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.C61G?",
      "search_query": "\"Olaparib\" AND BRCA1 AND ovarian cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "Ovarian Neoplasms",
        "Phthalazines",
        "Piperazines",
        "BRCA1 Protein",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "BRCA2 Protein",
        "Middle Aged",
        "Cell Line, Tumor",
        "Aged",
        "Adult",
        "ovarian cancer",
        "Mutation",
        "Drug Resistance, Neoplasm",
        "Olaparib",
        "Ovarian cancer",
        "PARP inhibitor",
        "Antineoplastic Agents",
        "Antineoplastic Combined Chemotherapy Protocols"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_029",
      "question": "What mechanisms does Olaparib target in breast cancer with p.K3326*?",
      "search_query": "\"Olaparib\" AND BRCA2 AND breast cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "BRCA2 Protein",
        "BRCA1 Protein",
        "Phthalazines",
        "Piperazines",
        "Breast Neoplasms",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Middle Aged",
        "Aged",
        "Adult",
        "Olaparib",
        "Mutation",
        "Triple Negative Breast Neoplasms",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Germ-Line Mutation",
        "Antineoplastic Agents",
        "Ovarian Neoplasms",
        "olaparib",
        "BRCA"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_030",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.K3326*?",
      "search_query": "\"Olaparib\" AND BRCA2 AND prostate cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Male",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Prostatic Neoplasms, Castration-Resistant",
        "Phthalazines",
        "Piperazines",
        "BRCA2 Protein",
        "Prostatic Neoplasms",
        "Mutation",
        "BRCA1 Protein",
        "Antineoplastic Agents",
        "Neoplasm Metastasis",
        "Prostate cancer",
        "prostate cancer",
        "Olaparib",
        "Aged",
        "BRCA2",
        "DNA Repair",
        "PARP inhibitor",
        "Middle Aged"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_031",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.R346fs?",
      "paper_count": 0,
      "top_keywords": [
        "target",
        "mechanism",
        "mechanisms",
        "olaparib",
        "ovarian",
        "cancer"
      ],
      "keyword_counts": {
        "target": 2,
        "mechanism": 1,
        "mechanisms": 1,
        "olaparib": 1,
        "ovarian": 1,
        "cancer": 1
      },
      "method": "portal"
    },
    {
      "query_id": "SL_032",
      "question": "What mechanisms does Ceralasertib target in breast cancer with p.R175H?",
      "paper_count": 0,
      "top_keywords": [
        "target",
        "mechanism",
        "mechanisms",
        "ceralasertib",
        "breast",
        "cancer"
      ],
      "keyword_counts": {
        "target": 2,
        "mechanism": 1,
        "mechanisms": 1,
        "ceralasertib": 1,
        "breast": 1,
        "cancer": 1
      },
      "method": "portal"
    },
    {
      "query_id": "SL_033",
      "question": "What mechanisms does Adavosertib target in prostate cancer with p.R175H?",
      "paper_count": 0,
      "top_keywords": [
        "target",
        "mechanism",
        "mechanisms",
        "adavosertib",
        "prostate",
        "cancer"
      ],
      "keyword_counts": {
        "target": 2,
        "mechanism": 1,
        "mechanisms": 1,
        "adavosertib": 1,
        "prostate": 1,
        "cancer": 1
      },
      "method": "portal"
    },
    {
      "query_id": "SL_034",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "search_query": "\"Olaparib\" AND ATM AND ovarian cancer",
      "paper_count": 42,
      "top_keywords": [
        "Humans",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Female",
        "Phthalazines",
        "Piperazines",
        "Cell Line, Tumor",
        "Ataxia Telangiectasia Mutated Proteins",
        "Ovarian Neoplasms",
        "PARP inhibitor",
        "Animals",
        "Antineoplastic Agents",
        "BRCA1 Protein",
        "ATM",
        "olaparib",
        "Drug Resistance, Neoplasm",
        "DNA Damage",
        "Drug Synergism",
        "ovarian cancer",
        "Neoplasms",
        "Mutation"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_035",
      "question": "What mechanisms does Olaparib target in breast cancer with p.??",
      "search_query": "\"Olaparib\" AND PALB2 AND breast cancer",
      "paper_count": 32,
      "top_keywords": [
        "Humans",
        "Female",
        "Piperazines",
        "Phthalazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Breast Neoplasms",
        "BRCA2 Protein",
        "BRCA1 Protein",
        "Middle Aged",
        "Mutation",
        "Fanconi Anemia Complementation Group N Protein",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Adult",
        "Aged",
        "Male",
        "PARP inhibitors",
        "Triple Negative Breast Neoplasms",
        "PALB2",
        "Antineoplastic Agents",
        "Olaparib"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_036",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "search_query": "\"Olaparib\" AND RAD51C AND prostate cancer",
      "paper_count": 3,
      "top_keywords": [
        "Humans",
        "Male",
        "Phthalazines",
        "Piperazines",
        "Adolescent",
        "Adult",
        "Antineoplastic Combined Chemotherapy Protocols",
        "Pain",
        "Physicians",
        "Prostatic Neoplasms, Castration-Resistant",
        "Quality of Life",
        "Recombinational DNA Repair",
        "Abdominal Pain",
        "Adenocarcinoma",
        "Biopsy",
        "Carcinoembryonic Antigen",
        "Checkpoint Kinase 2",
        "Chromosomes, Human, Pair 22",
        "Colorectal Neoplasms",
        "DNA Copy Number Variations"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_037",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.??",
      "search_query": "\"Olaparib\" AND RAD51D AND ovarian cancer",
      "paper_count": 6,
      "top_keywords": [
        "Humans",
        "Female",
        "Genomic Instability",
        "Ovarian Neoplasms",
        "Mutation",
        "Phthalazines",
        "Piperazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "DNA-Binding Proteins",
        "Recombinational DNA Repair",
        "Adult",
        "Aged",
        "Middle Aged",
        "BRCA1 Protein",
        "BRCA2 Protein",
        "Clinical Trials as Topic",
        "Genomic instability",
        "Olaparib",
        "Ovarian cancer",
        "Translational research"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_038",
      "question": "What mechanisms does Ceralasertib target in breast cancer with p.??",
      "search_query": "\"Ceralasertib\" AND ARID1A AND breast cancer",
      "paper_count": 1,
      "top_keywords": [
        "DNA-Binding Proteins",
        "Endometrial Neoplasms",
        "Female",
        "Humans",
        "Indoles",
        "Morpholines",
        "Multicenter Studies as Topic",
        "Neoplasm Recurrence, Local",
        "Ovarian Neoplasms",
        "Phthalazines",
        "Piperazines",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "Protein Kinase Inhibitors",
        "Pyrimidines",
        "Sulfonamides",
        "Transcription Factors",
        "cervical cancer",
        "endometrial neoplasms",
        "ovarian cancer"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_039",
      "question": "What mechanisms does Olaparib target in prostate cancer with p.??",
      "search_query": "\"Olaparib\" AND CDK12 AND prostate cancer",
      "paper_count": 12,
      "top_keywords": [
        "Humans",
        "Male",
        "Prostatic Neoplasms, Castration-Resistant",
        "Mutation",
        "Antineoplastic Agents",
        "Phthalazines",
        "Piperazines",
        "Prostate cancer",
        "Aged",
        "Aged, 80 and over",
        "Middle Aged",
        "Prostatic Neoplasms",
        "Recombinational DNA Repair",
        "PARP inhibitors",
        "HRR",
        "PARPi",
        "olaparib",
        "Genes, BRCA1",
        "Neoplasm Metastasis",
        "Olaparib"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "SL_040",
      "question": "What mechanisms does Olaparib target in ovarian cancer with p.C61G?",
      "search_query": "\"Olaparib\" AND BRCA1 AND ovarian cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Female",
        "Ovarian Neoplasms",
        "Phthalazines",
        "Piperazines",
        "BRCA1 Protein",
        "Poly(ADP-ribose) Polymerase Inhibitors",
        "BRCA2 Protein",
        "Middle Aged",
        "Cell Line, Tumor",
        "Aged",
        "Adult",
        "ovarian cancer",
        "Mutation",
        "Drug Resistance, Neoplasm",
        "Olaparib",
        "Ovarian cancer",
        "PARP inhibitor",
        "Antineoplastic Agents",
        "Antineoplastic Combined Chemotherapy Protocols"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "HV_001",
      "question": "How does Vitamin D help with ovarian cancer?",
      "search_query": "\"Vitamin D\" AND ovarian cancer",
      "paper_count": 100,
      "top_keywords": [
        "Humans",
        "Vitamin D",
        "Female",
        "Ovarian Neoplasms",
        "Receptors, Calcitriol",
        "Vitamins",
        "vitamin D",
        "Aged",
        "ovarian cancer",
        "Middle Aged",
        "Cell Line, Tumor",
        "Male",
        "Adult",
        "Risk Factors",
        "Animals",
        "Dietary Supplements",
        "Calcitriol",
        "Ovarian cancer",
        "Cell Proliferation",
        "Cholecalciferol"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    },
    {
      "query_id": "HV_002",
      "question": "How does Omega-3 Fatty Acids (EPA/DHA) help with ovarian cancer?",
      "paper_count": 0,
      "top_keywords": [
        "ovarian"
      ],
      "keyword_counts": {
        "ovarian": 1
      },
      "method": "portal"
    },
    {
      "query_id": "HV_003",
      "question": "How does Folate + Vitamin B12 help with ovarian cancer?",
      "paper_count": 0,
      "top_keywords": [
        "folate",
        "vitamin",
        "ovarian"
      ],
      "keyword_counts": {
        "folate": 1,
        "vitamin": 1,
        "ovarian": 1
      },
      "method": "portal"
    },
    {
      "query_id": "HV_004",
      "question": "How does Curcumin (Turmeric) help with ovarian cancer?",
      "paper_count": 0,
      "top_keywords": [
        "curcumin",
        "ovarian"
      ],
      "keyword_counts": {
        "curcumin": 1,
        "ovarian": 1
      },
      "method": "portal"
    },
    {
      "query_id": "HV_005",
      "question": "How does Green Tea (EGCG) help with ovarian cancer?",
      "paper_count": 0,
      "top_keywords": [
        "ovarian"
      ],
      "keyword_counts": {
        "ovarian": 1
      },
      "method": "portal"
    },
    {
      "query_id": "HV_006",
      "question": "How does NAC (N-Acetylcysteine) help with ovarian cancer?",
      "search_query": "\"NAC (N-Acetylcysteine)\" AND ovarian cancer",
      "paper_count": 2,
      "top_keywords": [
        "Humans",
        "Autophagy",
        "Female",
        "Proto-Oncogene Proteins p21(ras)",
        "Reactive Oxygen Species",
        "Cell Line, Tumor",
        "Ovarian Neoplasms",
        "Pancreatic Neoplasms",
        "Carcinoma, Pancreatic Ductal",
        "Chloroquine",
        "DIRAS3",
        "KRAS",
        "LGSOC",
        "PDAC",
        "chloroquine",
        "Anthraquinones",
        "Antineoplastic Agents",
        "HL-60 Cells",
        "Cordia oncocalyx",
        "1,4-benzoquinone"
      ],
      "keyword_counts": {},
      "method": "portal_analysis"
    }
  ]
}